![](/img/cover-not-exists.png)
Use of daclizumab in the immunosuppression of high-risk kidney and kidney/pancreas recipients: Warsaw transplantation center experience
T Bączkowska, K Kukula, E Nowacka-Cieciura, T Cieciura, D Lewandowska, R Ciecierski, T Grochowiecki, W Rowinski, J Szmidt, M Durlik, M LaoVolume:
34
Year:
2002
Language:
english
DOI:
10.1016/s0041-1345(01)02842-1
File:
PDF, 46 KB
english, 2002